5-methoxy-alpha-methyltryptamine has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 1 studies
*4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist [MeSH]
*4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, HH; Lynch, VM; May, JA; McLaughlin, MA; Rusinko, A; Sharif, NA | 1 |
1 other study(ies) available for 5-methoxy-alpha-methyltryptamine and 4-iodo-2,5-dimethoxyphenylisopropylamine
Article | Year |
---|---|
A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Blood Pressure; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Indoles; Inhibitory Concentration 50; Macaca fascicularis; Models, Molecular; Ocular Hypertension; Radioligand Assay; Rats; Receptors, Adrenergic; Receptors, Serotonin; Recombinant Proteins; Serotonin Receptor Agonists; Stereoisomerism | 2003 |